Lung Cancer Research News

Hijacked Cell Signals May Trigger Most Common Lung Cancer

An ACS grantee is among the scientists that pinpointed the most prominent cell of origin for the most common type of lung cancer. Now a new molecular profiling technique is giving him a never-before-seen-look at the cells of concern. What he's learning could lead to treatments that target the specific origin of adenocarcinoma.

New Report Underscores Lung Cancer Risk From Silica

A new report, published in CA: A Cancer Journal for Clinicians, highlights the link between silica and lung cancer. The paper, authored by researchers from the American Cancer Society and Emory University, reviewed recent studies that “provide new information about silica and lung cancer.” They note that the findings underscore what more than 100 other studies conducted to date have shown – that there is “strong and consistent evidence that silica exposure increases lung cancer risk.”

Next Cancer Breakthroughs May Occur in Unexpected Places

In the past, cancer research and fundraising often focused on a specific cancer type, such as breast cancer or lymphoma. Today, research increasingly shows that the next breakthroughs are more likely to occur in unexpected places.

One-On-One Help May Work to Get Minorities to Stop Smoking

Finding lung cancer early—or better yet, preventing it—among underserved minorities is the goal of American Cancer Society-funded researcher Sanja Percac-Lima, M.D., Ph.D., who will use patient navigators to help patients quit smoking and get screened.

Report Forecasts Worsening Smoking Epidemic in Africa

Africa is poised to become the “future epicenter of the tobacco epidemic,” according to a new analysis from the American Cancer Society. It warns that the number of adults in Africa who smoke could increase to 572 million by 2100, from 77 million today, unless leaders take steps to curb current trends.

Repurposing Existing Drugs to Fight Lung Cancer

Discovering a new use for existing drugs is the goal of American Cancer Society-funded researcher Curtis Chong, M.D., Ph.D., who is searching for a targeted agent that can treat drug-resistant lung cancer. Read more here.

Research Under Way for Lung Cancer Dream Team

The Lung Cancer Dream Team is specifically focused on a difficult-to-treat lung cancer with a common gene mutation called KRAS, which occurs in 20-30% of lung cancers. Learn more here.

The Study That Helped Spur the U.S. Stop-Smoking Movement

Most Americans born into the generations that came after the Baby Boom have gone their entire lives aware that smoking can cause lung cancer. But this fact has not always been well-known – and at one time it wasn’t known at all.